Vetter joins United Nations Global Compact Network

Vetter (Ravensbury, Germany), the aseptic filling and packaging CDMO has signed up to the UN Global Compact Network.
They join 308 other biopharmaceutical companies who are also a part of the agreement to work towards more sustainable business practices. Outside of the biopharmaceutical field, over 15,000 companies and 3,000 not-for-profit organisations, from 160 countries, are included in the network.
The Network is defined by ten principles, which Vetter will now have to follow as part of it’s corporate actions. The main focus of the principles is upholding human and employee rights, engaging tactics to prevent corruption, and to limit global warming.
Henryk Badack, Senior Vice President Technical Service and Internal Project Management at Vetter explained:
"We have already been pursuing a very ambitious sustainability strategy for years. By committing to the goals of the UN Global Compact, we are reaching the next level and are further expanding our initiatives to a global level."
As a collaborative network, Vetter will be able to join forces with the other companies within the agreement to work towards the same goals. The initiative means that these companies and organisations can share knowledge, ideas, and resources in the hope of upgrading processes and inciting change across the industry. Vetter will be held accountable to the goals of the compact network through a written annual report that will be open to the public, which doubles as evidence of the project and a progress report to inform the wider network.
"As a family-owned business in the healthcare sector, we bear great responsibility,” stated Badack. “And we believe in the power of cooperation. The UN Global Compact combines these two approaches very well and is also a strong commitment to shared values and goals across business sectors and national borders."
Vetter had already in place a set of it’s own sustainability values and targets, the combination will serve to better support their customers in ensuring a more sustainable supply chain and more ESG-friendly operations.
Join a global discussion at CPHI Barcelona
What does the UN Global Compact Network mean for your business – and the wider pharma industry? Join us at CPHI Barcelona and hear from expert speakers about the many, varied ways we can all work towards more sustainable practices.
Your CPHI Barcelona pass gives you access to all conference sessions, including the Creating a Circular Economy conference track, as well as the chance to connect in-person with the global pharma supply chain from 24-26 October, at Fira Barcelona Gran Via. Browse the agenda and secure your pass today!

Related News
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines. -
News Women in Pharma: Manufacturing personal and team success
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive... -
News Pfizer may shift production back to US under Trump pharma tariffs
At the 45th TD Cowen annual healthcare conference in Boston, USA, Pfizer CEO Albert Bourla outlined the potential for Pfizer to shift its overseas drug manufacturing back to the US as pharmaceutical industry players weigh their options against Presiden... -
News Experimental drug for managing aortic valve stenosis shows promise
The new small molecule drug ataciguat is garnering attention for its potential to manage aortic valve stenosis, which may prevent the need for surgery and significantly improve patient experience. -
News Women in Pharma: Connecting accessible pharma packaging to patients – a Pharmapack Special
Throughout our Women in Pharma series, we aim to highlight how CPHI events encourage discussions around diversity, equity, and inclusion initiatives in the pharmaceutical industry. -
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries. -
News Trump administration halts global supply of HIV, malaria, tuberculosis drugs
In various memos circulated to the United States Agency for International Development (USAID), the Trump administration has demanded contractors and partners to immediately stop work in supplying lifesaving drugs for HIV, malaria, and tuberculosis to c... -
News 2024 Drug Approvals: a lexicon of notable drugs and clinical trials
50 drugs received FDA approval in 2024. The centre for biologics evaluation and research also identified six new Orphan drug approvals as under Biologics License Applications (BLAs). The following list picks out key approvals from the list, and highlig...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance